Experts have reportedly succeeded in detecting anti-avian influenza virus antibody in the blood serum within 20 minutes. They use a portable analyzer that they have developed in order to conduct rapid on-site bio tests.
SciTechDaily just revealed that is a suitable reagent is developed, such technology could be also used in order to detect antibodies against the SARS-CoV-2 – the novel coronavirus that causes COVID-19, the disease that hit the world like never before in our generation.
Avian influenza is a poultry disease that is caused by influenza A virus infection.
Rapid initial response for suspected infection and continuous surveillance are vital in order to mitigate the damage from such dangerous viruses such as the avian influenza ones.
A new study for testing antibodies
It’s been also reported that generally, the polymerase chain reaction (PCR) way of testing is used in order to detect the viral genome, but it’s also important to note the fact that this is a complex and complicated procedure that required a lengthy amount of time.
Another way of testing involves detecting antibodies that are produced in the body in reaction to virus infection. On the other hand, the widely used antibody detection methods can be inaccurate because the existence of the antibodies is usually determined by eyesight.
Experts have now conducted a new study to help them develop a new way and analyzer that’s capable to making rapid, easy, and selective detection of antibodies. The analyzer is a small portable device that weighs only 5.5 kg.
Manabu Tokeshi of the university’s Faculty of Engineering conducted this study.
“Our analyzer could be used to conduct other bio tests if suitable reagents are developed,” according to Tokeshi.
He continued and explained that “By reproducing fragments of spike proteins expressed in the novel coronavirus, and using them as the reagent, the analyzer should be able to detect anti-coronavirus antibodies.”